Peter S Garcia - Net Worth and Insider Trading
Peter S Garcia Net Worth
The estimated net worth of Peter S Garcia is at least $1 Million dollars as of 2024-12-29. Peter S Garcia is the Vice President, CFO of PDL BioPharma Inc and owns about 472,842 shares of PDL BioPharma Inc (PDLI) stock worth over $1 Million. Peter S Garcia is the CHIEF FINANCIAL OFFICER of ALX Oncology Holdings Inc and owns about 122,348 shares of ALX Oncology Holdings Inc (ALXO) stock worth over $198,204. Peter S Garcia is also the CFO of Lineage Cell Therapeutics Inc and owns about 7,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $3,479. Details can be seen in Peter S Garcia's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter S Garcia has not made any transactions after 2024-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter S Garcia
Peter S Garcia Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter S Garcia owns 6 companies in total, including ALX Oncology Holdings Inc (ALXO) , PDL BioPharma Inc (PDLI) , and Lineage Cell Therapeutics Inc (LCTX) among others .
Click here to see the complete history of Peter S Garcia’s form 4 insider trades.
Insider Ownership Summary of Peter S Garcia
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALXO | ALX Oncology Holdings Inc | 2024-06-13 | Chief Financial Officer |
PDLI | PDL BioPharma Inc | 2019-03-28 | Vice President & CFO |
LCTX | Lineage Cell Therapeutics Inc | 2012-03-19 | Chief Financial Officer |
2009-07-13 | Chief Financial Officer | ||
2004-05-07 | Senior V.P. and C.F.O. | ||
2021-12-13 | director |
Peter S Garcia Latest Holdings Summary
Peter S Garcia currently owns a total of 3 stocks. Among these stocks, Peter S Garcia owns 472,842 shares of PDL BioPharma Inc (PDLI) as of March 24, 2017, with a value of $1 Million and a weighting of 85.27%. Peter S Garcia owns 122,348 shares of ALX Oncology Holdings Inc (ALXO) as of June 13, 2024, with a value of $198,204 and a weighting of 14.47%. Peter S Garcia also owns 7,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of March 19, 2012, with a value of $3,479 and a weighting of 0.25%.
Latest Holdings of Peter S Garcia
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PDLI | PDL BioPharma Inc | 2017-03-24 | 472,842 | 2.47 | 1,167,920 |
ALXO | ALX Oncology Holdings Inc | 2024-06-13 | 122,348 | 1.62 | 198,204 |
LCTX | Lineage Cell Therapeutics Inc | 2012-03-19 | 7,000 | 0.50 | 3,479 |
Holding Weightings of Peter S Garcia
Peter S Garcia Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter S Garcia has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the acquisition of 25,000 shares on March 24, 2017, which cost Peter S Garcia around $49,500.
According to the SEC Form 4 filings, Peter S Garcia has made a total of 8 transactions in ALX Oncology Holdings Inc (ALXO) over the past 5 years, including 3 buys and 5 sells. The most-recent trade in ALX Oncology Holdings Inc is the acquisition of 12,000 shares on June 13, 2024, which cost Peter S Garcia around $102,360.
According to the SEC Form 4 filings, Peter S Garcia has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 5,000 shares on March 19, 2012, which cost Peter S Garcia around $23,400.
Insider Trading History of Peter S Garcia
- 1
Peter S Garcia Trading Performance
GuruFocus tracks the stock performance after each of Peter S Garcia's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter S Garcia is -12.09%. GuruFocus also compares Peter S Garcia's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter S Garcia within 3 months outperforms 4 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter S Garcia's insider trading performs compared to the benchmark.
Performance of Peter S Garcia
Peter S Garcia Ownership Network
Peter S Garcia Owned Company Details
What does ALX Oncology Holdings Inc do?
Who are the key executives at ALX Oncology Holdings Inc?
Peter S Garcia is the Chief Financial Officer of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include VP & Finance and CAO Shelly Pinto , Chief Medical Officer Sophia Randolph , and director & President and CEO Jaume Pons .
ALX Oncology Holdings Inc (ALXO) Insider Trades Summary
Over the past 18 months, Peter S Garcia made 3 insider transaction in ALX Oncology Holdings Inc (ALXO) with a net purchase of 23,113. Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 145,903 shares made by Jaume Pons , a net sale of 14,288 shares made by Shelly Pinto , and a net sale of 18,243 shares made by Sophia Randolph .
In summary, during the past 3 months, insiders sold 0 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 30,000 shares, with a net purchase of 30,000 shares. During the past 18 months, 179,321 shares of ALX Oncology Holdings Inc (ALXO) were sold and 58,400 shares were bought by its insiders, resulting in a net sale of 120,921 shares.
ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ALX Oncology Holdings Inc Insider Transactions
Peter S Garcia Mailing Address
Above is the net worth, insider trading, and ownership report for Peter S Garcia. You might contact Peter S Garcia via mailing address: Alx Oncology Holdings Inc., 866 Malcolm Road, Suite 100, Burlingame Ca 94010.